Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    June 2024
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    >> Share

  2. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    >> Share

  3. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    >> Share

    Offline: The system is not working.
    Lancet. 2024;403:2470.
    >> Share

    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    >> Share

    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    >> Share

    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    >> Share

  8. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    >> Share

    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    >> Share

  10. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    >> Share

  11. HORTON R
    Offline: UK election-two issues you won't hear about.
    Lancet. 2024;403:2362.
    >> Share

    May 2024
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    >> Share

    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    >> Share

  14. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    >> Share

    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    >> Share

  16. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    >> Share

    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    >> Share

  18. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    >> Share

  19. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    >> Share

  20. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    >> Share

  21. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    >> Share

  22. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    >> Share

  23. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    >> Share

  24. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    >> Share

  25. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    >> Share

  26. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    >> Share

  27. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    >> Share

  28. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    >> Share

  29. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    >> Share

  30. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    >> Share

    April 2024
  31. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    >> Share

  32. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    >> Share

  33. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    >> Share

  34. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    >> Share

  35. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    >> Share

  36. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    >> Share

  37. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    >> Share

  38. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    >> Share

  39. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    >> Share

  40. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    >> Share

  41. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    >> Share

  42. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    >> Share

  43. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    >> Share

  44. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    >> Share

    March 2024
  45. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    >> Share

  46. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    >> Share

  47. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    >> Share

  48. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    >> Share

  49. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    >> Share

    February 2024
  50. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    >> Share

  51. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    >> Share

  52. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    >> Share

    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    >> Share

  54. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    >> Share

  55. WANG X, Li Y, Shi T, Bont LJ, et al
    Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
    >> Share

  56. ADERINTO N, Olatunji G, Kokori E
    Health implications of GSK's departure from Nigeria.
    Lancet. 2024;403:526-527.
    >> Share

    January 2024
  57. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
    The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
    >> Share

  58. WANG L, Wang Q, Gao GF
    Interpreting COVID-19 data from China: a call for caution - Authors' reply.
    Lancet. 2024;403:144-145.
    >> Share

  59. QU Z
    Interpreting COVID-19 data from China: a call for caution.
    Lancet. 2024;403:144.
    >> Share

  60. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    >> Share

  61. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
    >> Share

  62. SHAH SA, Robertson C, Sheikh A
    Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
    Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
    >> Share

    December 2023
  63. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
    Louis Pasteur, COVID-19, and the social challenges of epidemics.
    Lancet. 2023;400:2166-2168.
    >> Share

    Death and end of life in France after COVID-19.
    Lancet. 2023;402:2290.
    >> Share

  65. HORTON R
    Offline: Boris Johnson and COVID-19-more light than heat.
    Lancet. 2023;402:2277.
    >> Share

    November 2023
  66. GRABAR-KITAROVIC K, Phumaphi J
    A crisis of trust in pandemic prevention, preparedness, and response.
    Lancet. 2023;402:1730-1732.
    >> Share

  67. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    >> Share

  68. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    >> Share

  69. Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    >> Share

  70. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    >> Share

  71. MARTIN A, Jamieson S
    Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    >> Share

  72. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
    Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    >> Share

  73. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    >> Share

  74. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
    Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    >> Share

  75. HAZIR SG, Ryan C, Moore A, Lewis C, et al
    The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    >> Share

  76. DU Z, Wang L, Bai Y, Pei Y, et al
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    >> Share

  77. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
    Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    >> Share

    October 2023
  78. WANG Q, Bowen A, Ho J, Zhang RM, et al
    SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
    Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
    >> Share

  79. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
    Scientific advisory councils in the COVID-19 response.
    Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
    >> Share

    September 2023
    Natural SARS-CoV-2 infection-induced immune protection against re-infection.
    Lancet. 2023;402:1131.
    >> Share

  81. FLACCO ME, Martellucci CA, Manzoli L
    Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Lancet. 2023;402:1129.
    >> Share

  82. YANG C, Lapp L, Tebbutt SJ
    Overcoming COVID-19 vaccine hesitancy hurdles.
    Lancet. 2023;402:1129-1130.
    >> Share

  83. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
    Striving to afford free health care in Greece during COVID-19.
    Lancet. 2023;402:1128-1129.
    >> Share

  84. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
    Long COVID in low-income and middle-income countries: the hidden public health crisis.
    Lancet. 2023;402:1115-1117.
    >> Share

  85. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
    Lancet. 2023;402:1132.
    >> Share

  86. QU Z
    Cautionary notes on the COVID-19 re-infection study.
    Lancet. 2023;402:1130-1131.
    >> Share

  87. ZHOU YB, Xu ZG
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
    Lancet. 2023;402:1131-1132.
    >> Share

  88. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
    Community COVID-19 response in WHO's European region.
    Lancet. 2023;402:1127.
    >> Share

  89. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    >> Share

  90. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    >> Share

  91. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    >> Share

    August 2023
  92. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    >> Share

  93. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    >> Share

  94. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    >> Share

  95. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    >> Share

    July 2023
  96. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    >> Share

  97. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    >> Share

  98. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    >> Share

    June 2023
  99. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
    Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
    Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
    >> Share

  100. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    >> Share

  101. PELOSI A
    Disrespectful language about patients with long COVID.
    Lancet. 2023;401:2108.
    >> Share

  102. PRIYA GIRI S, Dubey A
    Loneliness in the time of COVID-19: an alarming rise.
    Lancet. 2023;401:2107-2108.
    >> Share

  103. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
    Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
    Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
    >> Share

  104. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
    Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
    Lancet. 2023;401:2021-2023.
    >> Share

  105. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    >> Share

  106. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    >> Share

  107. LAL A, Schwalbe N
    Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery.
    Lancet. 2023;401:1847.
    >> Share

    May 2023
  108. JAFFE S
    US health experts divided on social media age restrictions.
    Lancet. 2023;401:1757.
    >> Share

  109. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
    Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
    >> Share

  110. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    >> Share

    With the COVID-19 PHEIC over, what next?
    Lancet. 2023;401:1642-1643.
    >> Share

  112. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
    Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
    Lancet. 2023;401:1649.
    >> Share

  113. JAFFE S
    US Surgeon General: loneliness is a public health crisis.
    Lancet. 2023;401:1560.
    >> Share

  114. EMANUEL EJ, Persad G
    The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
    Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
    >> Share

    April 2023
  115. AGRAWAL U, Robertson C, Sheikh A
    Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
    Lancet. 2023;401:1424.
    >> Share

  116. BRANCH-ELLIMAN W, Monach PA
    Moving towards a precision approach for prevention of severe COVID-19.
    Lancet. 2023;401:1423-1424.
    >> Share

  117. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
    The importance of accountability in tackling future pandemics.
    Lancet. 2023;401:1423.
    >> Share

  118. GALVAO J
    COVID-19: forgetting a pandemic that is not over.
    Lancet. 2023;401:1422-1423.
    >> Share

    Moving past the COVID-19 emergency in the USA.
    Lancet. 2023;401:1399.
    >> Share

  120. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
    Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
    >> Share

  121. CUENI T
    Lessons learned from COVID-19 to stop future pandemics.
    Lancet. 2023;401:1340.
    >> Share

  122. HORTON R
    Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
    Lancet. 2023;401:1324.
    >> Share

  123. LURIE N, Sharfstein JM
    State-to-state differences in US COVID-19 outcomes: searching for explanations.
    Lancet. 2023;401:1314-1315.
    >> Share

  124. BILLARD MN, Bont LJ
    The link between respiratory syncytial virus infection during infancy and asthma during childhood.
    Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
    >> Share

  125. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
    Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
    Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
    >> Share

  126. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
    Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
    Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
    >> Share

  127. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
    Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
    Lancet. 2023;401:e20.
    >> Share

  128. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
    Characteristics of the omicron XBB subvariant wave in Singapore.
    Lancet. 2023;401:1261-1262.
    >> Share

  129. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
    Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
    Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
    >> Share

  130. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
    >> Share

  131. PERNER A, Venkatesh B
    Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
    Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
    >> Share

    March 2023
  132. SUN L, Jia H, Yang T
    Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1000.
    >> Share

  133. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
    Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
    >> Share

  134. QU Z
    International cooperation to end the COVID-19 pandemic.
    Lancet. 2023;401:820.
    >> Share

    Long COVID: 3 years in.
    Lancet. 2023;401:795.
    >> Share

  136. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    Lancet. 2023;401:833-842.
    >> Share

  137. COHEN C, Pulliam J
    COVID-19 infection, reinfection, and the transition to endemicity.
    Lancet. 2023;401:798-800.
    >> Share

    Effect of a nationwide intervention of electronic letters with behavioural nudges on influenza vaccination in older adults in Denmark.
    Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453.
    >> Share

  139. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
    Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349.
    >> Share

  140. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
    Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
    Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
    >> Share

    February 2023
  141. HUANG S, Gao Z, Wang S
    China's COVID-19 reopening measures-warriors and weapons.
    Lancet. 2023;401:643-644.
    >> Share

  142. HAY SI, Murray CJL
    Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Lancet. 2023;401:433-434.
    >> Share

  143. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432-433.
    >> Share

    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432.
    >> Share

  145. MOETI M, Makubalo L, Gueye AS, Balde T, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  146. O'NEILL D
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    >> Share

  147. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431-432.
    >> Share

  148. PAN Y, Wang L, Feng Z, Xu H, et al
    Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
    >> Share

  149. PREISER W, Maponga T
    So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
    Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
    >> Share

  150. TAN H, Liu J, Zeng F
    China needs a scientific long COVID recovery-support platform.
    Lancet. 2023;401:344-345.
    >> Share

    January 2023
  151. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
    Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
    >> Share

  152. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
    Global and regional governance of One Health and implications for global health security.
    Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
    >> Share

  153. TRAORE T, Shanks S, Haider N, Ahmed K, et al
    How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
    Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
    >> Share

  154. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
    A global analysis of One Health Networks and the proliferation of One Health collaborations.
    Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
    >> Share

  155. ELLINGTON S, Jatlaoui TC
    COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
    Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
    >> Share

  156. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
    Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
    >> Share

    The COVID-19 pandemic in 2023: far from over.
    Lancet. 2023;401:79.
    >> Share

  158. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
    COVID-19 and other pandemics require a coherent response strategy.
    Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
    >> Share

    December 2022
  159. TIBBLE H, Mueller T, Proud E, Hall E, et al
    Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
    Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
    >> Share

  160. KIDD MR, Kelly PM
    PANORAMIC: important insights into molnupiravir use in COVID-19.
    Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
    >> Share

  161. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
    Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
    >> Share

  162. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
    Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
    Lancet. 2022;400:2109-2124.
    >> Share

  163. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
    Racism, xenophobia, discrimination, and the determination of health.
    Lancet. 2022;400:2097-2108.
    >> Share

  164. ELSON W, Zambon M, de Lusignan S
    Integrated respiratory surveillance after the COVID-19 pandemic.
    Lancet. 2022;400:1924-1925.
    >> Share

    November 2022
  165. JAFFE S
    US CDC begins agency-wide changes after pandemic failures.
    Lancet. 2022;400:1754-1755.
    >> Share

  166. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    >> Share

  167. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
    Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
    Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
    >> Share

  168. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
    WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
    >> Share

  169. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    >> Share

    October 2022

  170. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
    >> Share

  171. FRENK J, Chen LC, Chandran L, Groff EOH, et al
    Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
    Lancet. 2022;400:1539-1556.
    >> Share

  172. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
    >> Share

  173. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
    The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
    Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
    >> Share

  174. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
    After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
    Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
    >> Share

  175. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
    Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2022;400:1305-1320.
    >> Share

  176. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
    Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
    Lancet. 2022;400:1304.
    >> Share

  177. IRVING SA, Sundaram ME
    Prioritisation of COVID-19 boosters in the omicron era.
    Lancet. 2022;400:1282-1283.
    >> Share

  178. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    >> Share

  179. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    >> Share

  180. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
    A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
    Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
    >> Share

  181. WU MY, Carr EJ, Harvey R, Mears HV, et al
    WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
    Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
    >> Share

    September 2022
  182. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
    Characterising adults in Scotland who are not vaccinated against COVID-19.
    Lancet. 2022;400:993-995.
    >> Share

  183. ZIEGLER T, Moen A, Zhang W, Cox NJ, et al
    Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected.
    Lancet. 2022;400:981-982.
    >> Share

    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    >> Share

  185. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    >> Share

  186. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    >> Share

  187. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    >> Share

  188. ZHANG Y, Wang Y, Ning G, He P, et al
    Protecting older people: a high priority during the COVID-19 pandemic.
    Lancet. 2022;400:729-730.
    >> Share

    New centre for pandemic therapeutics.
    Lancet. 2022;400:722.
    >> Share

    August 2022
  190. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Lancet. 2022;400:693-706.
    >> Share

  191. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    >> Share

  192. PICKERSGILL M, Manda-Taylor L, Nino-Machado N
    Pandemic preparedness means policy makers need to work with social scientists.
    Lancet. 2022;400:547-549.
    >> Share

  193. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    >> Share

    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    >> Share

  195. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    >> Share

  196. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    >> Share

    July 2022

  197. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  199. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share

  200. DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
    Lancet. 2022;400:392-406.
    >> Share

  201. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    >> Share

  202. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    >> Share

    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  204. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    >> Share

  205. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share

  206. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share

  207. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    >> Share

  208. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    >> Share

    June 2022
  209. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    >> Share

    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    >> Share

  211. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    >> Share

  212. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    >> Share

  213. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    >> Share

  214. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    >> Share

  215. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    >> Share

  216. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    >> Share

  217. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    >> Share

    May 2022
  218. HARTERT TV, Ortiz JR
    Need for improved global measurement of early childhood respiratory syncytial virus disease.
    Lancet. 2022;399:1993-1995.
    >> Share

  219. LI Y, Wang X, Blau DM, Caballero MT, et al
    Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Lancet. 2022;399:2047-2064.
    >> Share

  220. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    >> Share

  221. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    >> Share

  222. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    >> Share

  223. HORTON R
    Offline: How to fix pandemic preparedness.
    Lancet. 2022;399:1927.
    >> Share

  224. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    >> Share

  225. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    >> Share

    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    >> Share

    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    >> Share

  228. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    >> Share

  229. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    >> Share

  230. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    >> Share

  231. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    >> Share

  232. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    >> Share

    April 2022
  233. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    >> Share

  234. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    >> Share

  235. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    >> Share

  236. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    >> Share

  237. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    >> Share

  238. NTOUMI F, Zumla A
    Advancing accurate metrics for future pandemic preparedness.
    Lancet. 2022;399:1443-1445.
    >> Share

  239. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    >> Share

  240. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    >> Share

  241. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    >> Share

  242. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    >> Share

  243. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    >> Share

  244. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    >> Share

  245. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    >> Share

  246. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    >> Share

  247. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    >> Share

  248. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    >> Share

    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    >> Share

  250. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    >> Share

  251. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    >> Share

    March 2022
  252. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    >> Share

  253. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    >> Share

  254. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    >> Share

  255. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    >> Share

  256. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    >> Share

  257. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    >> Share

  258. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

  259. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    >> Share

  260. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    >> Share

  261. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    >> Share

  262. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    >> Share

  263. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    >> Share

  264. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    >> Share

  265. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    >> Share

  266. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    >> Share

  267. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    >> Share

  268. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    >> Share

  269. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    >> Share

  270. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    >> Share

  271. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    >> Share

    February 2022
  272. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    >> Share

  273. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    >> Share

    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    >> Share

  275. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    >> Share

  276. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    >> Share

  277. PIECHOTTA V, Harder T
    Waning of COVID-19 vaccine effectiveness: individual and public health risk.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
    >> Share

  278. FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
    Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
    >> Share

  279. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    >> Share

  280. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    >> Share

  281. DINEEN K, Autzen B, Alwan NA
    Children, intersectionality, and COVID-19.
    Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
    >> Share

  282. SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
    Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
    Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
    >> Share

  283. EGGER S, Egger G
    The vaccinated propor-tion of people with COVID-19 needs context.
    Lancet. 2022;399:627.
    >> Share

  284. MUSSINI C, Cozzi-Lepri A
    Another piece in the COVID-19 treatment puzzle.
    Lancet. 2022;399:609-610.
    >> Share

  285. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    >> Share

  286. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2022;399:665-676.
    >> Share

  287. LOPEZ A, Srigley J
    Transmission of SARS-CoV-2: still up in the air.
    Lancet. 2022;399:519.
    >> Share

  288. GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
    Transmission of SARS-CoV-2: still up in the air - Authors' reply.
    Lancet. 2022;399:519-520.
    >> Share

  289. DALY M, Robinson E
    Depression and anxiety during COVID-19.
    Lancet. 2022;399:518.
    >> Share

  290. SANTOMAURO DF, Whiteford HA, Ferrari AJ
    Depression and anxiety during COVID-19 - Authors' reply.
    Lancet. 2022;399:518-519.
    >> Share

    Ayoade Alakija: advancing equity in the COVID-19 response.
    Lancet. 2022;399:511.
    >> Share

    WHO concerned over COVID-19 health-care waste.
    Lancet. 2022;399:507.
    >> Share

  293. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    >> Share

  294. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    >> Share

    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    >> Share

  296. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

  297. NORDSTROM P, Ballin M, Nordstrom A
    Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
    >> Share

  298. KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
    COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
    >> Share

  299. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
    >> Share

    January 2022
  300. HOLT E
    Polish Government COVID-19 advisors resign.
    Lancet. 2022;399:424.
    >> Share

  301. NEALON J, Cowling BJ
    Omicron severity: milder but not mild.
    Lancet. 2022;399:412-413.
    >> Share

  302. ADAMS R
    Urgent care: disability, pandemic, and the value of a life.
    Lancet. 2022;399:430-431.
    >> Share

  303. JAFFE S
    The next steps for US vaccine mandates.
    Lancet. 2022;399:425-426.
    >> Share

  304. SO-OSMAN C, Valk SJ
    High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
    >> Share

  305. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
    >> Share

  306. HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
    Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
    >> Share

  307. FENDLER A, Shepherd STC, Au L, Wu M, et al
    Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
    >> Share

  308. TANG TB
    The COVID-19 response in Hong Kong.
    Lancet. 2022;399:357.
    >> Share

  309. ALFIERI C, Egrot M, Desclaux A, Sams K, et al
    Recognising Italy's mistakes in the public health response to COVID-19.
    Lancet. 2022;399:357-358.
    >> Share

  310. QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
    Intersectionality and developing evidence-based policy.
    Lancet. 2022;399:355-356.
    >> Share

  311. BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
    Long COVID and self-management.
    Lancet. 2022;399:355.
    >> Share

  312. LANE R
    Jamal Rifi: family doctor building bridges in the community.
    Lancet. 2022;399:353.
    >> Share

  313. COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
    Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
    >> Share

  314. BRAVO L, Smolenov I, Han HH, Li P, et al
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
    >> Share

    Trimeric S protein COVID-19 vaccine needs to find its place.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
    >> Share

  316. CARR EJ, Wu M, Harvey R, Billany RE, et al
    Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
    >> Share

  317. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    >> Share

    COVID-19 will continue but the end of the pandemic is near.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
    >> Share

  319. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    >> Share

  320. KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
    Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
    >> Share

    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    >> Share

  322. VALAIYAPATHI R, Wu MS, McGregor A
    Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
    Lancet. 2022;399:270.
    >> Share

    The UK People's Covid Inquiry.
    Lancet. 2022;399:236.
    >> Share

  324. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

  325. HARMAN S
    The wall.
    Lancet. 2022;399:136-137.
    >> Share

  326. BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
    COVID-19 ARDS: getting ventilation right - Authors' reply.
    Lancet. 2022;399:22-23.
    >> Share

  327. PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
    COVID-19 ARDS: getting ventilation right.
    Lancet. 2022;399:22.
    >> Share

  328. HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
    Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
    Lancet. 2022;399:21-22.
    >> Share

    The state of science and society in 2022.
    Lancet. 2022;399:1.
    >> Share

    December 2021
  330. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
    >> Share

  331. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    >> Share

    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
    >> Share

  333. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
    >> Share

  334. LEUNG K, Wu JT
    Managing waning vaccine protection against SARS-CoV-2 variants.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
    >> Share

  335. KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
    Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
    >> Share

  336. DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
    Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
    >> Share

  337. PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
    Diagnostics for COVID-19: moving from pandemic response to control.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
    >> Share

    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    >> Share

    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    >> Share

    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    >> Share

  341. HALL V, Hopkins S
    COV-BOOST: evidence to support rapid booster deployment.
    Lancet. 2021;398:2209-2211.
    >> Share

    COVID-19: where do we go from here?
    Lancet. 2021;398:2207.
    >> Share

  343. MOLLICA RF, Fricchione GL
    Mental and physical exhaustion of health-care practitioners.
    Lancet. 2021;398:2243-2244.
    >> Share

    WHO and World Bank urge spending for UHC.
    Lancet. 2021;398:2223.
    >> Share

  345. DEVI S
    Russia-Ukraine tensions hampering health-care access.
    Lancet. 2021;398:2222.
    >> Share

    Projecting COVID-19 disruption to elective surgery.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
    >> Share

  347. MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
    COVID-19 vaccine strategies must focus on severe disease and global equity.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
    >> Share

  348. BRADBURY CA, McQuilten Z
    Anticoagulation in COVID-19.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
    >> Share

  349. RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
    >> Share

  350. LIPWORTH B, Chan R, Misirovs R
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2147.
    >> Share

  351. HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
    High-dose budesonide for early COVID-19 - Authors' reply.
    Lancet. 2021;398:2147-2148.
    >> Share

  352. BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2146-2147.
    >> Share

    Preventing violence against women: beyond 16 days.
    Lancet. 2021;398:2125.
    >> Share

  354. MOON S, Armstrong J, Hutler B, Upshur R, et al
    Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
    Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
    >> Share

    Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
    >> Share

  356. STUART ASV, Shaw RH, Liu X, Greenland M, et al
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
    >> Share

  357. DEVI S
    Health warnings over UNRWA funding shortfall.
    Lancet. 2021;398:2063.
    >> Share

    Hope for nutrition summit as global hunger spikes.
    Lancet. 2021;398:2061-2062.
    >> Share

  359. WARD H, Flower B, Garcia PJ, Ong SWX, et al
    Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
    Lancet. 2021;398:2057-2059.
    >> Share

  360. KARIM SSA, Karim QA
    Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
    >> Share

  361. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    >> Share

  362. MUNRO APS, Janani L, Cornelius V, Aley PK, et al
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
    >> Share

    November 2021
  363. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    >> Share

  364. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    COVID-19 and myocardial infarction - Authors' reply.
    Lancet. 2021;398:1964.
    >> Share

  365. SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
    Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Lancet. 2021;398:1963.
    >> Share

  366. CALDEIRA D, Pinto FJ
    COVID-19 and myocardial infarction.
    Lancet. 2021;398:1963-1964.
    >> Share

  367. BOUM Y
    Beyond COVID-19: scaling up and sustaining mobile health in Africa.
    Lancet. 2021;398:1962-1963.
    >> Share

  368. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    >> Share

  369. SMITH K, Brooks W, Challiner J, Povey E, et al
    Quality assurance of remote clinical assessments in the NHS.
    Lancet. 2021;398:1962.
    >> Share

  370. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

  371. FLEMING KA, Horton S, Wilson ML, Atun R, et al
    The Lancet Commission on diagnostics: transforming access to diagnostics.
    Lancet. 2021;398:1997-2050.
    >> Share

  372. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    >> Share

  373. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    >> Share

  374. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    >> Share

  375. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    >> Share

  376. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    >> Share

  377. KNEEBONE R, Houstoun W, Houghton N
    Medicine, magic, and online performance.
    Lancet. 2021;398:1868-1869.
    >> Share

  378. BURKI T
    mRNA discoveries earn the 2021 Prince Mahidol Award.
    Lancet. 2021;398:1865.
    >> Share

  379. SPYROPOULOS AC, Bonaca MP
    Studying the coagulopathy of COVID-19.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
    >> Share

  380. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
    >> Share

  381. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    >> Share

  382. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    >> Share

  383. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    >> Share

  384. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    >> Share

  385. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    >> Share

  386. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    >> Share

  387. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.
    >> Share

    The choice to love.
    Lancet. 2021;398:1680-1681.
    >> Share

  389. USHER AD
    New budget and strategy for ACT-A.
    Lancet. 2021;398:1677.
    >> Share

    WHO's Tedros set to be re-elected unopposed.
    Lancet. 2021;398:1676.
    >> Share

    Can digital technologies improve health?
    Lancet. 2021;398:1663.
    >> Share

  392. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    >> Share

  393. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    >> Share

    October 2021
  394. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.
    >> Share

  395. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.
    >> Share

    Nicaraguan health-care workers under attack.
    Lancet. 2021;398:1555-1556.
    >> Share

  397. BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
    The World Health Network: a global citizens' initiative.
    Lancet. 2021;398:1567-1568.
    >> Share

  398. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    >> Share

  399. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    >> Share

  400. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
    >> Share

  401. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    >> Share

  402. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.
    >> Share

  403. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.
    >> Share

  404. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.
    >> Share

  405. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.
    >> Share

  406. RICCIARDI W, Tarricone R
    The evolution of the Italian National Health Service.
    Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
    >> Share

  407. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
    >> Share

  408. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share

  409. LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
    Lancet. 2021;398:1304.
    >> Share

  410. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
    Lancet. 2021;398:1303-1304.
    >> Share

  411. MYERS SS, Pivor JI, Saraiva AM
    The Sao Paulo Declaration on Planetary Health.
    Lancet. 2021;398:1299.
    >> Share

  412. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
    >> Share

  413. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    >> Share

  414. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
    >> Share

  415. KLEINERT S, Horton R
    Can COVID-19 help accelerate and transform the diagnostics agenda?
    Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
    >> Share

  416. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    >> Share

  417. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    >> Share

  418. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
    >> Share

  419. TORRES I, Profeta B, Machado CV, Artaza O, et al
    COVID-19 research in LMICs - Authors' reply.
    Lancet. 2021;398:1213.
    >> Share

  420. SISA I, Fornasini M, Teran E
    COVID-19 research in LMICs.
    Lancet. 2021;398:1212-1213.
    >> Share

    ECMO in COVID-19: do not blame the tool.
    Lancet. 2021;398:1197-1199.
    >> Share

  422. BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
    Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
    Lancet. 2021;398:1230-1238.
    >> Share

  423. VINER RM, Koirala A
    Daily antigen testing to reduce disruption when schools return.
    Lancet. 2021;398:1196-1197.
    >> Share

    September 2021
  424. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
    >> Share

    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.
    >> Share

  426. AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
    Functioning of the International Health Regulations during the COVID-19 pandemic.
    Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
    >> Share

  427. OGBUOJI O, Mao W, Aryeetey G
    The long-term impact of COVID-19 on development assistance for health is still uncertain.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
    >> Share

  428. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
    >> Share

  429. WU Z, Jin Q, Wu G, Lu J, et al
    SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
    >> Share

  430. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    >> Share

  431. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    >> Share

  432. SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
    Uncoupling vaccination from politics: a call to action.
    Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
    >> Share

  433. YOUNG BC, Eyre DW, Kendrick S, White C, et al
    Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
    >> Share

  434. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    >> Share

  435. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    >> Share

    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.
    >> Share

  437. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    >> Share

  438. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    >> Share

  439. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    >> Share

  440. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    >> Share

  441. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.
    >> Share

    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    >> Share

  443. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    >> Share

    August 2021
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    >> Share

  445. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    >> Share

  446. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    >> Share

  447. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    >> Share

  448. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    >> Share

  449. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    >> Share

  450. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    >> Share

  451. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    >> Share

  452. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    >> Share

  453. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    >> Share

  454. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    >> Share

  455. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    >> Share

    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    >> Share

  457. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    >> Share

  458. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    >> Share

  459. ADEPOJU P
    West Africa on alert for haemorrhagic fevers.
    Lancet. 2021;398:653.
    >> Share

  460. USHER AD
    Health leaders criticise limited ACT-A review.
    Lancet. 2021;398:650-651.
    >> Share

  461. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    >> Share

  462. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    >> Share

    Focusing on island health.
    Lancet. 2021;398:569-570.
    >> Share

    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    >> Share

  465. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    >> Share

  466. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    >> Share

    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    >> Share

  468. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    >> Share

  469. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    >> Share

  470. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    >> Share

  471. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    >> Share

  472. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    >> Share

  473. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    >> Share

  474. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    >> Share

  475. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    >> Share

  476. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    >> Share

  477. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    >> Share

  478. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    >> Share

  479. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  480. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    >> Share

  481. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    >> Share

    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    >> Share

  483. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    >> Share

  484. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    >> Share

    July 2021
  485. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share

  486. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  487. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  488. IJSSELMUIDEN C, Ntoumi F, Lavery JV, Montoya J, et al
    Should global financing be the main priority for pandemic preparedness?
    Lancet. 2021;398:388.
    >> Share

    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.
    >> Share

  490. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share

  491. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    >> Share

  492. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    >> Share

  493. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.
    >> Share

  494. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.
    >> Share

  495. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.
    >> Share

  496. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.
    >> Share

  497. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    >> Share

  498. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    >> Share

    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.
    >> Share

  500. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    >> Share

  501. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    >> Share

  502. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    >> Share

  503. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    >> Share

  504. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.
    >> Share

  505. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.
    >> Share

  506. IDROVO AJ
    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.
    >> Share

    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    >> Share

  508. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    >> Share

  509. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
    >> Share

  510. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    >> Share

  511. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    >> Share

  512. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    WHO COVID-19 therapeutic guidelines - Authors' reply.
    Lancet. 2021;398:118.
    >> Share

  513. ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
    WHO COVID-19 therapeutic guidelines.
    Lancet. 2021;398:117-118.
    >> Share

  514. ALSABA K
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
    Lancet. 2021;398:116.
    >> Share

  515. NABETH P, Hassan M, Adib K, Abubakar A, et al
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
    Lancet. 2021;398:116-117.
    >> Share

    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    >> Share

  517. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.
    >> Share

  518. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.
    >> Share

  519. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    >> Share

  520. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    >> Share

  521. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
    >> Share

  522. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    >> Share

  523. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    >> Share

    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    >> Share

  525. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    >> Share

    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    >> Share

  527. KICKBUSCH I, Leung GM, Shattock RJ
    Learning from crisis: building resilient systems to combat future pandemics.
    Lancet. 2021;398:e2-e6.
    >> Share

  528. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    >> Share

    June 2021
  529. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    >> Share

  530. KUMAR D, Mittal M
    India's COVID-19 emergency: overarching conclusions belie facts.
    Lancet. 2021;397:2465.
    >> Share

  531. SAHA K
    Can India's COVID-19 emergency be fixed without politics?
    Lancet. 2021;397:2465-2466.
    >> Share

  532. VISARIA A, Dharamdasani T
    The complex causes of India's 2021 COVID-19 surge.
    Lancet. 2021;397:2464.
    >> Share

    India's COVID-19 response: science first.
    Lancet. 2021;397:2464-2465.
    >> Share

  534. DUTTA R, Kucchal T
    India's pain: beyond COVID-19 case numbers and mortality rates.
    Lancet. 2021;397:2463.
    >> Share

    Colombians protest over inequities and health care.
    Lancet. 2021;397:2454.
    >> Share

  536. DUARTE-SALLES T, Prieto-Alhambra D
    Heterologous vaccine regimens against COVID-19.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
    >> Share

  537. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    >> Share

  538. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    >> Share

    Protecting refugees during the COVID-19 pandemic.
    Lancet. 2021;397:2309.
    >> Share

  540. BARRON GC, Koonin J
    A call to action on UHC commitments.
    Lancet. 2021;397:2335-2336.
    >> Share

  541. USHER AD
    A beautiful idea: how COVAX has fallen short.
    Lancet. 2021;397:2322-2325.
    >> Share

  542. KC S, Ananthakrishnan A, Painter C, Butani D, et al
    Research collaboration is needed to inform quarantine policies for health-care workers.
    Lancet. 2021;397:2334.
    >> Share

    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
    >> Share

  544. SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
    Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
    >> Share

  545. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.
    >> Share

  546. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.
    >> Share

  547. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.
    >> Share

  548. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.
    >> Share

  549. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.
    >> Share

  550. GUBRIUM A, Gubrium E
    Narrative complexity in the time of COVID-19.
    Lancet. 2021;397:2244-2245.
    >> Share

  551. BERGER JS, Connors JM
    Anticoagulation in COVID-19: reaction to the ACTION trial.
    Lancet. 2021;397:2226-2228.
    >> Share

    Kirsten Ostherr: mobilising the translational humanities.
    Lancet. 2021;397:2243.
    >> Share

    We need a global conversation on the 2020 Olympic Games.
    Lancet. 2021;397:2225.
    >> Share

  554. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
    >> Share

  555. EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
    From routine data collection to policy design: sex and gender both matter in COVID-19.
    Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
    >> Share

  556. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    >> Share

  557. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    >> Share

    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    >> Share

  559. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    >> Share

  560. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    >> Share

  561. USHER AD
    ACT Accelerator strains donors' aid budgets.
    Lancet. 2021;397:2137.
    >> Share

  562. LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
    Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
    >> Share

  563. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
    >> Share

  564. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    >> Share

  565. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    >> Share

    May 2021
  566. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    >> Share

  567. TATUM M
    Cambodia ends controversial COVID-19 restrictions.
    Lancet. 2021;397:2035.
    >> Share

  568. DEVI S
    Yemen's health system has "collapsed", warns UN.
    Lancet. 2021;397:2036.
    >> Share

  569. DEVI S
    800 000 South Sudanese to lose access to health care.
    Lancet. 2021;397:2034.
    >> Share

  570. AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
    India's resurgence of COVID-19: urgent actions needed.
    Lancet. 2021 May 25. pii: S0140-6736(21)01202.
    >> Share

  571. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    >> Share

  572. JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
    Refugee access to COVID-19 vaccines in Lebanon.
    Lancet. 2021;397:1884.
    >> Share

  573. NESAMONEY SN, Darmstadt GL, Wise PH
    Gendered effects of COVID-19 on young girls in regions of conflict.
    Lancet. 2021;397:1880-1881.
    >> Share

    What next for a COVID-19 intellectual property waiver?
    Lancet. 2021;397:1871-1872.
    >> Share

  575. KIRENGA BJ, Byakika-Kibwika P
    Excess COVID-19 mortality among critically ill patients in Africa.
    Lancet. 2021;397:1860-1861.
    >> Share

  576. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.
    >> Share

    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    >> Share

  578. HUANG L, Gu X, Wang Y, Huang C, et al
    Long-term effects of COVID-19 on kidney function - Authors' reply.
    Lancet. 2021;397:1807-1808.
    >> Share

  579. WATSON SI
    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.
    >> Share

  580. DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1807.
    >> Share

  581. ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1806-1807.
    >> Share

  582. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.
    >> Share

  583. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.
    >> Share

  584. GENC K
    COVID-19 in Turkey: a nation on edge.
    Lancet. 2021;397:1794-1796.
    >> Share

  585. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.
    >> Share

  586. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    >> Share

  587. HIMMELSTEIN DU, Woolhandler S
    Recovering from Trump: Biden's first 100 days.
    Lancet. 2021;397:1787-1791.
    >> Share

  588. LIU STH, Aberg JA
    Convalescent plasma in patients hospitalised with COVID-19.
    Lancet. 2021 May 14. pii: S0140-6736(21)01064.
    >> Share

  589. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.
    >> Share

  590. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.
    >> Share

  591. MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
    Disease surveillance for the COVID-19 era: time for bold changes.
    Lancet. 2021 May 14. pii: S0140-6736(21)01096.
    >> Share

  592. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00897.
    >> Share

  593. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
    Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Lancet. 2021 May 12. pii: S0140-6736(21)00894.
    >> Share

  594. SHAW RH, Stuart A, Greenland M, Liu X, et al
    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Lancet. 2021 May 12. pii: S0140-6736(21)01115.
    >> Share

  595. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    >> Share

  596. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.
    >> Share

  597. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.
    >> Share

  598. FUJIWARA Y, Onda Y, Hayashi S
    No-fault compensation schemes for COVID-19 medical products.
    Lancet. 2021;397:1707-1708.
    >> Share

  599. HE S, Bala R, Anupindi R, Ranney ML, et al
    Effective supply chain surveillance for PPE.
    Lancet. 2021;397:1706-1707.
    >> Share

  600. DEVI S
    COVID-19 surge threatens health in the Gaza strip.
    Lancet. 2021;397:1698.
    >> Share

    India's COVID-19 emergency.
    Lancet. 2021;397:1683.
    >> Share

  602. MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
    Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Lancet. 2021;397:1711-1724.
    >> Share

  603. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.
    >> Share

  604. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.
    >> Share

    UK makes massive global health cuts.
    Lancet. 2021;397:1697.
    >> Share

  606. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.
    >> Share

  607. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.
    >> Share

  608. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.
    >> Share

  609. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.
    >> Share

  610. Priorities for COVID-19 research response and preparedness in low-resource settings.
    Lancet. 2021 May 6. pii: S0140-6736(21)00980.
    >> Share

  611. ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
    LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
    Lancet. 2021 May 6. pii: S0140-6736(21)00232.
    >> Share

  612. CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
    What is the right level of spending needed for health and care in the UK?
    Lancet. 2021 May 6. pii: S0140-6736(21)00230.
    >> Share

  613. ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
    Securing a sustainable and fit-for-purpose UK health and care workforce.
    Lancet. 2021 May 6. pii: S0140-6736(21)00231.
    >> Share

  614. MCKEE M, Dunnell K, Anderson M, Brayne C, et al
    The changing health needs of the UK population.
    Lancet. 2021 May 6. pii: S0140-6736(21)00229.
    >> Share

  615. LESHEM E, Wilder-Smith A
    COVID-19 vaccine impact in Israel and a way out of the pandemic.
    Lancet. 2021 May 5. pii: S0140-6736(21)01018.
    >> Share

  616. HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
    Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Lancet. 2021 May 5. pii: S0140-6736(21)00947.
    >> Share

  617. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.
    >> Share

  618. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.
    >> Share

  619. FOGSTAD H
    Women, children, and adolescents in the post-pandemic world.
    Lancet. 2021;397:1620.
    >> Share

  620. HYDE R
    Controversy surrounds Merkel's new lockdown powers.
    Lancet. 2021;397:1610.
    >> Share

  621. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021;397:1637-1645.
    >> Share

    April 2021
  622. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
    Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
    >> Share

  623. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.
    >> Share

  624. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.
    >> Share

  625. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.
    >> Share

  626. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.
    >> Share

  627. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.
    >> Share

    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.
    >> Share

  629. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.
    >> Share

    Global health and its discontents.
    Lancet. 2021;397:1543-1544.
    >> Share

  631. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
    >> Share

  632. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    >> Share

  633. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
    >> Share

  634. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
    >> Share

  635. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.
    >> Share

  636. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
    >> Share

  637. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
    >> Share

  638. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    >> Share

  639. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
    >> Share

    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    >> Share

    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    >> Share

  642. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.
    >> Share

  643. CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
    The ultra-connected generation would like to disconnect now.
    Lancet. 2021;397:1350.
    >> Share

  644. ANDREWS K
    Racism is the public health crisis.
    Lancet. 2021;397:1342-1343.
    >> Share

  645. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
    >> Share

  646. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    >> Share

  647. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
    >> Share

  648. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    >> Share

  649. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    >> Share

  650. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    >> Share

  651. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    >> Share

  652. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    >> Share

  653. HE S, Lai D, Lee J
    The medical right to repair: the right to save lives.
    Lancet. 2021;397:1260-1261.
    >> Share

    New EU health programme comes into force.
    Lancet. 2021;397:1252-1253.
    >> Share

  655. JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
    10 years of the Syrian conflict: a time to act and not merely to remember.
    Lancet. 2021;397:1245-1248.
    >> Share

  656. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
    >> Share

    March 2021
  657. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    >> Share

  658. SANDERS RW, de Jong MD
    Pandemic moves and countermoves: vaccines and viral variants.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
    >> Share

  659. MYLAN S, Hardman C
    COVID-19, cults, and the anti-vax movement.
    Lancet. 2021;397:1181.
    >> Share

    COVID-19: building a stronger Europe.
    Lancet. 2021;397:1157.
    >> Share

  661. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.
    >> Share

  662. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
    >> Share

  663. KLUGE H, McKee M
    COVID-19 vaccines for the European region: an unprecedented challenge.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
    >> Share

  664. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    >> Share

  665. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    >> Share

  666. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    >> Share

  667. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    >> Share

  668. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    >> Share

  669. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    >> Share

  670. STRUGNELL R, Wang N
    Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
    Lancet. 2021;397:1037-1039.
    >> Share

  671. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
    COVID-19, community trials, and inclusion.
    Lancet. 2021;397:1036-1037.
    >> Share

  672. HE Z, Ren L, Yang J, Guo L, et al
    Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    Lancet. 2021;397:1075-1084.
    >> Share

  673. JAFFE S
    Biden's first legislative victory: $1.9 trillion for COVID-19.
    Lancet. 2021;397:1047-1048.
    >> Share

  674. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.
    >> Share

    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    >> Share

  676. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    >> Share

  677. BOYTON RJ, Altmann DM
    Risk of SARS-CoV-2 reinfection after natural infection.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
    >> Share

  678. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    >> Share

  679. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    >> Share

  680. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
    >> Share

  681. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    >> Share

    Access to COVID-19 vaccines: looking beyond COVAX.
    Lancet. 2021;397:941.
    >> Share

  683. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    >> Share

  684. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    >> Share

  685. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    >> Share

  686. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
    >> Share

  687. HUNG IFN, Poland GA
    Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
    Lancet. 2021;397:854-855.
    >> Share

  688. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    >> Share

    Robin Shattock: novel vaccine developer.
    Lancet. 2021;397:870.
    >> Share

  690. SROUR SA
    Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
    Lancet. 2021;397:861-862.
    >> Share

  691. SOE ZW, Oo MM, Wah KS, Naing AT, et al
    Myanmar's health leaders stand against military rule.
    Lancet. 2021;397:875.
    >> Share

  692. MADAD S, Spencer C
    The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
    >> Share

  693. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    >> Share

  694. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    >> Share

    February 2021
  695. CHAUVIN L
    Peruvian COVID-19 vaccine scandal spreads.
    Lancet. 2021;397:783.
    >> Share

    New WTO leader faces COVID-19 challenges.
    Lancet. 2021;397:782.
    >> Share

  697. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    >> Share

  698. MANISTY C, Otter AD, Treibel TA, McKnight A, et al
    Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
    >> Share

  699. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    >> Share

    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    >> Share

  701. GODDARD AF, Patel M
    The changing face of medical professionalism and the impact of COVID-19.
    Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
    >> Share

  702. SIVA N
    Severe mental illness: reassessing COVID-19 vaccine priorities.
    Lancet. 2021;397:657.
    >> Share

  703. HYDE R
    von der Leyen admits to COVID-19 vaccine failures.
    Lancet. 2021;397:655-656.
    >> Share

  704. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  705. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  707. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    >> Share

  708. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    >> Share

  709. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    >> Share

  710. ROBERTSON JFR, Sewell HF, Stewart M
    Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
    >> Share

  711. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    >> Share

  712. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    >> Share

  713. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    >> Share

  714. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    >> Share

  715. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
    >> Share

  716. SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
    Future scenarios for the COVID-19 pandemic.
    Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
    >> Share

  717. MAKONI M
    Tanzania refuses COVID-19 vaccines.
    Lancet. 2021;397:566.
    >> Share

    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.
    >> Share

  719. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    >> Share

  720. SINGH NS, Lokot M, Undie CC, Onyango MA, et al
    Research in forced displacement: guidance for a feminist and decolonial approach.
    Lancet. 2021;397:560-562.
    >> Share

    Improving prisoner health for stronger public health.
    Lancet. 2021;397:555.
    >> Share

  722. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
    >> Share

  723. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
    Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
    >> Share

  724. FONTANET A, Autran B, Lina B, Kieny MP, et al
    SARS-CoV-2 variants and ending the COVID-19 pandemic.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
    >> Share

  725. MARTIN S, Arawi T
    Ensure Palestinians have access to COVID-19 vaccines.
    Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
    >> Share

  726. BURKI T
    Understanding variants of SARS-CoV-2.
    Lancet. 2021;397:462.
    >> Share

    WHO team begins COVID-19 origin investigation.
    Lancet. 2021;397:459.
    >> Share

  728. GORNA R, MacDermott N, Rayner C, O'Hara M, et al
    Long COVID guidelines need to reflect lived experience.
    Lancet. 2021;397:455-457.
    >> Share

    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.
    >> Share

  730. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.
    >> Share

    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.
    >> Share

  732. CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
    A COVID-19 jab in the right direction.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
    >> Share

  733. KAMPF G, Kulldorff M
    Calling for benefit-risk evaluations of COVID-19 control measures.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
    >> Share

  734. MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
    Breastfeed or be vaccinated-an unreasonable default recommendation.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
    >> Share

  735. JONES I, Roy P
    Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
    >> Share

  736. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
    >> Share

  737. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
    >> Share

  738. FRIESEN P, Caplan AL, Miller JE
    COVID-19 vaccine research and the trouble with clinical equipoise.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
    >> Share

  739. TUYISENGE G, Goldenberg SM
    COVID-19, structural racism, and migrant health in Canada.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
    >> Share

    January 2021
  740. MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
    SARS-CoV-2 serosurveys in low-income and middle-income countries.
    Lancet. 2021;397:353-355.
    >> Share

    Fransisca Handy Agung: improving adolescent health in Indonesia.
    Lancet. 2021;397:365.
    >> Share

    Health experts slam Bolsonaro's vaccine comments.
    Lancet. 2021;397:361.
    >> Share

    Health and care workers are owed a better future.
    Lancet. 2021;397:347.
    >> Share

  744. HALLAL PC
    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.
    >> Share

  745. BLAKNEY AK, McKay PF
    Next-generation COVID-19 vaccines: here come the proteins.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
    >> Share

  746. RICHMOND P, Hatchuel L, Dong M, Ma B, et al
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
    >> Share

  747. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
    >> Share

  748. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
    >> Share

  749. SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
    Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
    Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
    >> Share

  750. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    >> Share

  751. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    Lancet. 2021;397:277-278.
    >> Share

  752. NASRALLAH MP, Mourelatos Z, Lee EB
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:277.
    >> Share

  753. GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276.
    >> Share

  754. EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276-277.
    >> Share

  755. AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
    Reaffirming health and safety precautionary principles for COVID-19 in the UK.
    Lancet. 2021;397:274.
    >> Share

  756. MAKONI M
    South Africa responds to new SARS-CoV-2 variant.
    Lancet. 2021;397:267.
    >> Share

  757. BHUYAN A
    India begins COVID-19 vaccination amid trial allegations.
    Lancet. 2021;397:264.
    >> Share

    COVID-19: the intersection of education and health.
    Lancet. 2021;397:253.
    >> Share

  759. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    >> Share

  760. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    >> Share

  761. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    >> Share

  762. PATEL MS, Phillips CB
    COVID-19 and the moral imagination.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
    >> Share

  763. PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
    An action plan for pan-European defence against new SARS-CoV-2 variants.
    Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
    >> Share

  764. IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
    Preparing for a COVID-19 resurgence in the WHO African region.
    Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
    >> Share

  765. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    >> Share

  766. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    >> Share

  767. WEBSTER P
    COVID-19 highlights Canada's care home crisis.
    Lancet. 2021;397:183.
    >> Share

  768. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    >> Share

  769. JAFFE S
    New leadership at the US CDC.
    Lancet. 2021;397:182.
    >> Share

    An opportunity for American renewal.
    Lancet. 2021;397:171.
    >> Share

  771. CAVALERI M, Enzmann H, Straus S, Cooke E, et al
    The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
    Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
    >> Share

  772. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    >> Share

  773. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    >> Share

  774. KUSIN S, Choo E
    Parenting in the time of COVID-19.
    Lancet. 2021;397:86.
    >> Share

  775. USHER AD
    Health systems neglected by COVID-19 donors.
    Lancet. 2021;397:83.
    >> Share

  776. KNEEBONE R, Schlegel C
    Thinking across disciplinary boundaries in a time of crisis.
    Lancet. 2021;397:89-90.
    >> Share

  777. COUSINS S
    Polio in Afghanistan: a changing landscape.
    Lancet. 2021;397:84-85.
    >> Share

  778. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
    Lancet. 2021;397:129-170.
    >> Share

  779. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    >> Share

  780. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    >> Share

    Health as a foundation for society.
    Lancet. 2021;397:1.
    >> Share

  782. DEVI S
    2021: a year of humanitarian need.
    Lancet. 2021;397:12-13.
    >> Share

  783. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.
    >> Share

  784. KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
    Germany's new global health strategy: leaving migrants behind.
    Lancet. 2021;397:20-21.
    >> Share

    Abolish race correction.
    Lancet. 2021;397:17-18.
    >> Share

  786. ROCHON PA, Stall NM, Gurwitz JH
    Making older women visible.
    Lancet. 2021;397:21.
    >> Share

    December 2020
  787. GOODMAN J, de Prudhoe K, Williams C
    UK COVID-19 public inquiry needed to learn lessons and save lives.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
    >> Share

  788. CLAESON M, Hanson S
    COVID-19 and the Swedish enigma.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
    >> Share

  789. HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
    COVID-19 vaccines and women's security.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
    >> Share

  790. SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
    Infectivity of asymptomatic versus symptomatic COVID-19.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
    >> Share

  791. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
    >> Share

  792. WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
    Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
    >> Share

  793. KUNG S, Doppen M, Black M, Hills T, et al
    Reduced mortality in New Zealand during the COVID-19 pandemic.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
    >> Share

  794. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    >> Share

  795. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.
    >> Share

  796. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.
    >> Share

  797. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.
    >> Share

  798. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.
    >> Share

  799. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.
    >> Share

    Facing up to long COVID.
    Lancet. 2020;396:1861.
    >> Share

  801. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    >> Share

  802. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    >> Share

  803. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    >> Share

  804. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.
    >> Share

    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.
    >> Share

  806. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    >> Share

  807. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    >> Share

    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    >> Share

  809. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    >> Share

    November 2020
    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.
    >> Share

  811. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.
    >> Share

  812. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.
    >> Share

    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    >> Share

  814. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    >> Share

  815. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    >> Share

  816. HILLS T, Kearns N, Kearns C, Beasley R, et al
    Influenza control during the COVID-19 pandemic.
    Lancet. 2020;396:1633-1634.
    >> Share

    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.
    >> Share

  818. GRIFFITHS C, Mitchell M, Burnand A
    More support needed for UK charity-funded medical research.
    Lancet. 2020;396:1616-1618.
    >> Share

  819. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
    >> Share

  820. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
    >> Share

  821. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    >> Share

  822. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.
    >> Share

    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    >> Share

  824. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    >> Share

  825. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    >> Share

  826. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    >> Share

  827. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    >> Share

  828. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
    >> Share

  829. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
    >> Share

  830. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
    >> Share

  831. KRIEGER N, Testa C, Hanage WP, Chen JT, et al
    US racial and ethnic data for COVID-19 cases: still missing in action.
    Lancet. 2020;396:e81.
    >> Share

    Surgery during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:e79.
    >> Share

  833. VUTHALURU S, Koliyadan SV, Kanniwadi SS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e78.
    >> Share

  834. MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e77.
    >> Share

    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e76.
    >> Share

  836. RODRIGUES J, Chan JK, Issa F
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e75.
    >> Share

  837. SHANTHANNA H, Uppal V
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e74.
    >> Share

  838. HAMID HKS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e73.
    >> Share

  839. HUNG IF, Yuen KY
    Early triple antiviral therapy for COVID-19 - Authors' reply.
    Lancet. 2020;396:1488.
    >> Share

  840. LEE N, Ison M, Dunning J
    Early triple antiviral therapy for COVID-19.
    Lancet. 2020;396:1487-1488.
    >> Share

  841. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Lancet. 2020;396:1486-1487.
    >> Share

  842. LODGE A
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1486.
    >> Share

  843. CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1485-1486.
    >> Share

  844. HOFFMANN C, Wolf E
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  845. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Lancet. 2020;396:1484-1485.
    >> Share

  846. GEORGE TP
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  847. DZAU VJ, Balatbat C
    Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
    Lancet. 2020;396:1469-1471.
    >> Share

    COVID-19 in Latin America: a humanitarian crisis.
    Lancet. 2020;396:1463.
    >> Share

  849. BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
    Institutional versus home isolation to curb the COVID-19 outbreak.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
    >> Share

  850. WILDER-SMITH A, Cook AR, Dickens BL
    Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
    >> Share

  851. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
    >> Share

  852. HOPKINS C, Smith B
    Widespread smell testing for COVID-19 has limited application.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
    >> Share

  853. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Widespread smell testing for COVID-19 has limited application - Authors' reply.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
    >> Share

    October 2020
  854. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.
    >> Share

  855. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.
    >> Share

  856. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.
    >> Share

  857. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.
    >> Share

  858. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.
    >> Share

  859. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.
    >> Share

  860. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.
    >> Share

  861. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.
    >> Share

  862. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.
    >> Share

  863. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
    >> Share

  864. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    >> Share

  865. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    >> Share

  866. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    >> Share

  867. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    >> Share

    Global health: time for radical change?
    Lancet. 2020;396:1129.
    >> Share

  869. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    >> Share

  870. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    >> Share

  871. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    >> Share

  872. WARD BJ, Makarkov A, Seguin A, Pillet S, et al
    Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (>/=65 years): two multicentre, randomised phase 3 trials.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32014.
    >> Share

    First human efficacy study of a plant-derived influenza vaccine.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32010.
    >> Share

  874. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    >> Share

  875. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    >> Share

  876. BLUKACZ A, Cabieses B
    COVID-19: leaving no one behind in Latin America.
    Lancet. 2020;396:1070.
    >> Share

  877. CHARLIER P, Varison L
    Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
    Lancet. 2020;396:1069-1070.
    >> Share

  878. KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
    Cancer and COVID-19 - Authors' reply.
    Lancet. 2020;396:1067-1068.
    >> Share

  879. MALEK AE, Raad II, Jabbour E
    Cancer and COVID-19.
    Lancet. 2020;396:1066-1067.
    >> Share

  880. MORIS D, Tsilimigras DI, Schizas D
    Cancer and COVID-19.
    Lancet. 2020;396:1066.
    >> Share

  881. GROSS R, Conzelmann C, Muller JA, Reister F, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1065-1066.
    >> Share

  882. CUMMINGS MJ, O'Donnell MR
    Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Lancet. 2020;396:1064.
    >> Share

  883. SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic.
    Lancet. 2020;396:1064-1065.
    >> Share

  884. PIOVANI D, Bonovas S
    Study of critically ill patients with COVID-19 in New York City.
    Lancet. 2020;396:1064.
    >> Share

  885. CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
    COVID-19, comics, and the visual culture of contagion.
    Lancet. 2020;396:1061-1063.
    >> Share

  886. COUSINS S
    2.5 million more child marriages due to COVID-19 pandemic.
    Lancet. 2020;396:1059.
    >> Share

    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    >> Share

  888. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    >> Share

  889. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    >> Share

  890. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    >> Share

  891. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
    >> Share

  892. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
    >> Share

  893. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
    >> Share

    Power of and power over COVID-19 response guidelines.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
    >> Share

  895. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    >> Share

  896. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    >> Share

  897. DENING KH, Lloyd-Williams M
    Minimising long-term effect of COVID-19 in dementia care.
    Lancet. 2020;396:957-958.
    >> Share

  898. WANG Y, Gu X, Xu J, Cao B, et al
    Remdesivir and COVID-19 - Authors' reply.
    Lancet. 2020;396:954.
    >> Share

  899. WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
    Remdesivir and COVID-19.
    Lancet. 2020;396:953-954.
    >> Share

  900. EDWARDS JK, Cole SR, Adimora AA
    Remdesivir and COVID-19.
    Lancet. 2020;396:953.
    >> Share

  901. GLAUS MJ, Von Ruden S
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  902. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    >> Share

    Building a resilient NHS, for COVID-19 and beyond.
    Lancet. 2020;396:935.
    >> Share

    September 2020
  904. CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
    Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
    >> Share

  905. STRATHDEE SA, Davies SC, Marcelin JR
    Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
    >> Share

  906. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.
    >> Share

  907. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.
    >> Share

  908. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.
    >> Share

  909. JAFFE S
    Media reports reveal political interference at the US CDC.
    Lancet. 2020;396:875.
    >> Share

    COVID-19 in India: the dangers of false optimism.
    Lancet. 2020;396:867.
    >> Share

  911. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.
    >> Share

  912. BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
    Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
    >> Share

  913. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  914. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    >> Share

  915. HAN E, Tan MMJ, Turk E, Sridhar D, et al
    Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
    Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
    >> Share

  916. LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
    >> Share

  917. BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
    >> Share

  918. PEIRIS M, Leung GM
    What can we expect from first-generation COVID-19 vaccines?
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
    >> Share

  919. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.
    >> Share

  920. KLEINERT S, Horton R
    Preprints with The Lancet are here to stay.
    Lancet. 2020;396:805.
    >> Share

  921. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    >> Share

  922. GALEA S, Ettman CK, Abdalla SM
    Access to health care and the 2020 US election.
    Lancet. 2020;396:803-805.
    >> Share

  923. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
    >> Share

  924. SLIWA K, Yacoub M
    Catalysing the response to NCDI Poverty at a time of COVID-19.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
    >> Share

    Global collaboration for health: rhetoric versus reality.
    Lancet. 2020;396:735.
    >> Share

  926. OLDENBURG CE, Doan T
    Azithromycin for severe COVID-19.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
    >> Share

  927. FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
    Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
    >> Share

  928. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
    >> Share

  929. LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
    >> Share

    August 2020
  930. FISHER DA, Carson G
    Back to basics: the outbreak response pillars.
    Lancet. 2020;396:598.
    >> Share

    April 2020
  931. CHENG KK, Lam TH, Leung CC
    Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity.
    Lancet. 2020 Apr 16. pii: S0140-6736(20)30918.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016